Form 4: Phreesia Director Michael Weintraub Exercises Options and Sells Shares Under Pre-Arranged 10b5-1 Plan

Phreesia, Inc. Director Michael Weintraub executed pre-arranged transactions in early June 2025, exercising stock options and subsequently selling 10,000 shares of common stock at market prices significantly above his exercise cost.

Summary

• Phreesia, Inc. (PHR) Director Michael Weintraub reported transactions involving the company's common stock on June 9 and June 10, 2025.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Weintraub on January 6, 2025.
• On June 9, 2025, Mr. Weintraub acquired 7,431 shares of common stock through the exercise of stock options at an exercise price of $4.71 per share.
• Immediately following the option exercise on June 9, 2025, he sold 7,431 shares at a weighted average price of $27.5123 per share, with prices ranging from $27.50 to $27.62.
• On June 10, 2025, Mr. Weintraub acquired an additional 2,569 shares of common stock by exercising stock options at $4.71 per share.
• Concurrently on June 10, 2025, he sold 2,569 shares at a weighted average price of $27.8582 per share, with prices ranging from $27.50 to $28.02.
• All exercised options were fully vested and exercisable as of the transaction dates.
• Following these transactions, Mr. Weintraub directly beneficially owns 143,039 shares of Phreesia common stock.
• He also indirectly beneficially owns 30,795 shares through the Michael Weintraub 2023 Qualified Annuity Trust (GRAT) and 6,703 shares through the Weintraub Family 2017 Irrevocable Trust.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While insider selling can sometimes be viewed negatively, the fact that these transactions were pre-arranged under a Rule 10b5-1 plan mitigates concerns about opportunistic selling. The director also realized significant gains from exercising options at a low price and selling at a much higher market price, indicating a successful personal investment strategy.

Positives

• The director exercised options at a significantly lower price ($4.71) compared to the market sale price (average of $27.51-$27.86), indicating a substantial personal gain and confidence in the stock's value at the time the options were granted.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests the sales were not based on new, non-public information and are part of a planned liquidity strategy.

Negatives

• The sale of shares by a director, even if pre-arranged, represents a reduction in insider ownership, which some investors might interpret as a lack of conviction, although this is mitigated by the 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. It reflects a director's personal financial planning rather than a strategic corporate move.

Corporate Governance

Related Party Transactions

• The reporting person indirectly holds 30,795 shares through the Michael Weintraub 2023 Qualified Annuity Trust (GRAT), of which he is the trustee and the Weintraub Family 2017 Irrevocable Trust is the beneficiary.
• The reporting person indirectly holds 6,703 shares through the Weintraub Family 2017 Irrevocable Trust, whose sole beneficiaries are members of the reporting person's immediate family.

Stakeholder Impact

• Shareholders: May observe the director's sale of shares. The pre-arranged nature of the sale under a 10b5-1 plan typically reduces concerns about the sale signaling negative company performance, as it's part of a planned financial strategy.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Phreesia, PHR, Form 4, Insider Trading, Stock Options, Share Sale, Michael Weintraub, 10b5-1 Plan, Beneficial Ownership, Director Transactions